For the past three years, various governments and patient advocacy groups have clamored for lower-cost hepatitis C medicines, given the high cure rate for these pricey new drugs. Now, a new study finds that upfront treatment with cheaper generic versions can offer a substantial payback.
“We assumed [generics] would be cost effective, given their high cure rates, but we wanted to know how quickly they saved costs,” said Jagpreet Chhatwal, a scientist at the Institute for Technology Assessment at Massachusetts General Hospital and one of the co-authors. “The results are not...
Read more about STAT: Generic hepatitis C meds really are very cost effective, study says